Evidence map›Paper›PMID 40114523›Full record

GuidelineUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2025

ISUOG/ESGO Consensus Statement on ultrasound-guided biopsy in gynecological oncology.

D Fischerova, F Planchamp, J L Alcázar, P Dundr, E Epstein, A Felix, F Frühauf, G Garganese, I Salvesen Haldorsen, D Jurkovic and 9 more

Abstract readPractice GuidelineConsensus Statement
In one paragraph

Guideline in Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

D FischerovaDepartment of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.ORCID 0000-0002-7224-3218
F PlanchampInstitut Bergonie, Bordeaux, France.
J L AlcázarUniversity of Navarra, Pamplona, Spain.
P DundrDepartment of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
E EpsteinDepartment of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
A FelixiNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal.
F FrühaufDepartment of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
G GarganeseUnità Operativa di Chirurgia dei Organi Genitali Esterni Femminili, Divisione di Ginecologia Oncologica, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
I Salvesen HaldorsenMohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University Hospital, Bergen, Norway.
D JurkovicEGA Institute for Women's Health, University College London, London, UK.ORCID 0000-0001-6487-5736
R KocianDepartment of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
D LengyelDepartment of Gynaecology, National Institute of Oncology, Budapest, Hungary.ORCID 0000-0002-7554-5537
F MasciliniUnità Operativa di Chirurgia dei Organi Genitali Esterni Femminili, Divisione di Ginecologia Oncologica, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
A StepanyanGynecologic Oncology Service, Nairi Medical Center, National Institute of Health, Yerevan, Armenia.
M StukanDepartment of Gynecological Oncology, Pomeranian Hospitals (Szpitale Pomorskie), Gdynia, Poland.ORCID 0000-0003-2376-4663
S TimmermanDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.ORCID 0000-0003-2253-7522
T VanasscheDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
Z Yuan NgDepartment of Gynaecological Oncology, KK Women's and Children's Hospital, Singapore.ORCID 0000-0003-0739-2775
U ScovazziAcademic Unit of Obstetrics and Gynecology, Hospital Polyclinic San Martino and University of Genoa, Genoa, Italy.ORCID 0000-0002-0989-8123

Funding

ESGOISUOG
6 · The paper itself

Abstract

The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) with the European Society of Gynaecological Oncology (ESGO) jointly developed clinically relevant and evidence-based statements on performing ultrasound-guided biopsies in gynecological oncology. The objective of this Consensus Statement is to assist clinicians, including gynecological sonographers, gynecological oncologists and radiologists, to achieve the best standards of practice in ultrasound-guided biopsy procedures. ISUOG/ESGO nominated a multidisciplinary international group of 16 experts who have demonstrated leadership in the use of ultrasound-guided biopsy in the clinical management of patients with gynecological cancer. In addition, two early-career gynecological fellows were nominated to participate from the European Network of Young Gynae Oncologists (ENYGO) within ESGO and from ISUOG. The group also included a patient representative from the European Network of Gynaecological Cancer Advocacy Groups. The document is divided into six sections: (1) general recommendations; (2) image-guided biopsy (imaging guidance, sampling methods); (3) indications and contraindications; (4) technique; (5) reporting; and (6) training and quality assurance. To ensure that the statements are evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on this review of the literature. During a conference call, the whole group discussed each preliminary statement, and a first round of voting was carried out. The group achieved consensus on all 46 preliminary statements without the need for revision. These ISUOG/ESGO statements on ultrasound-guided biopsy in gynecological oncology, together with a summary of the evidence supporting each statement, are presented herein. This Consensus Statement is supplemented by detailed narrated videoclips presenting different approaches and indications for ultrasound-guided biopsy, a patient leaflet, and an extended version which includes a detailed review of the evidence. © 2025 The Authors. Published by John Wiley & Sons Ltd on behalf of The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) and by Elsevier Inc. on behalf of the European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.

Indexed as

Genital Neoplasms, FemaleGynecologyImage-Guided BiopsyUltrasonography, InterventionalConsensusFemaleHumansMedical OncologySocieties, Medical

Identifiers

PMID40114523
PMCPMC11961111

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.